Skip to main content
OpenTrials

Clinical trial condition

Endocrine System Diseases

Explore clinical trials studying Endocrine System Diseases. Study availability and eligibility vary by location and protocol.

26,454 public trials 3,597 recruiting studies
Refine in advanced search Browse all conditions

Endocrine System Diseases trial results

Active, Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Conditions
Acute Myeloid Leukemia, Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, +98 more
Locations
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
View all 150 locations
View Trial Details
Active, Not Recruiting

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

NCT06914895

Conditions
Autoimmune Diseases, Body Weight, Diabetes Mellitus, +13 more
Locations
  • Sansum Diabetes Research Institute Santa Barbara, California, United States
  • Care Access - Santa Clarita Santa Clarita, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Atlanta Diabetes Associates Atlanta, Georgia, United States
View all 146 locations
View Trial Details
Active, Not Recruiting

Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia

NCT04490915

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
Locations
  • Neurocrine Clinical Site Los Angeles, California, United States
  • Neurocrine Clinical Site San Diego, California, United States
  • Neurocrine Clinical Site San Francisco, California, United States
  • Neurocrine Clinical Site Aurora, Colorado, United States
View all 70 locations
View Trial Details
Active, Not Recruiting

Community Engagement Alliance Against Disparities

NCT06607341

Conditions
Body Weight, Cardiovascular Diseases, Diabetes, +17 more
Locations
  • George Washington University, Milken Institute of Public Health Washington D.C., District of Columbia, United States
  • Johns Hopkins University School of Nursing Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

NCT04152499

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • Los Angeles Hematology Oncology Medical Group Glendale, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • START MidWest Grand Rapids, Michigan, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.

NCT07234864

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Emeritus Research Sydney Botany, New South Wales, Australia
  • Momentum Clinical Research Taringa Brisbane, Queensland, Australia
  • Momentum Clinical Research Sunshine Melbourne, Victoria, Australia
  • Emeritus Research Camberwell Melbourne, Victoria, Australia
View Trial Details

Related conditions